Skip to content
April 23, 2024

Equity.Guru

Investment information for the new generation

Search

SONA.C

Sona Nanotech (SONA.C), a developer of rapid, point-care diagnostic tests, announced today that it is discontinuing its previously announced clinical trial for its COVID-19 rapid, antigen saliva test. “Unfortunately,…